SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue zoomed 14.83% to Rs. 19678.60 millions for the quarter ended September 2021 as compared to Rs. 17137.80 millions during the corresponding quarter last year.The Company has registered profit of Rs. 6063.90  millions for the quarter ended September 2021, a growth of 18.14%  over Rs. 5133.00 millions millions achieved in the corresponding quarter of last year.Operating profit surged to 8377.00 millions from the corresponding previous quarter of 7460.30 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 19678.60 17137.80 14.83 39180.20 34237.40 14.44 67986.10 53105.70 28.02
Other Income 191.10 136.40 40.10 546.60 315.10 73.47 625.30 1898.60 -67.07
PBIDT 8377.00 7460.30 12.29 17247.20 14628.80 17.90 28832.10 20053.00 43.78
Interest 1.70 1.10 54.55 4.10 2.90 41.38 6.90 60.60 -88.61
PBDT 8375.30 7459.20 12.28 17243.10 14625.90 17.89 28825.20 19992.40 44.18
Depreciation 770.90 608.90 26.61 1501.00 1168.60 28.44 2546.50 1859.50 36.95
PBT 7604.40 6850.30 11.01 15742.10 13457.30 16.98 26278.70 18132.90 44.92
TAX 1540.50 1717.30 -10.30 4158.50 3401.80 22.24 6731.50 4405.80 52.79
Deferred Tax 202.20 273.20 -25.99 425.40 92.90 357.91 641.00 527.90 21.42
PAT 6063.90 5133.00 18.14 11583.60 10055.50 15.20 19547.20 13727.10 42.40
Equity 530.90 530.90 0.00 530.90 530.90 0.00 530.90 530.90 0.00
PBIDTM(%) 42.57 43.53 -2.21 44.02 42.73 3.03 42.41 37.76 12.31

Divis Lab Share Price

6228.95 -68.55 (-1.09%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×